Prognostic value of complete response after the initial treatment for malignant astrocytoma
- PMID: 8875449
- DOI: 10.1080/01616412.1996.11740429
Prognostic value of complete response after the initial treatment for malignant astrocytoma
Abstract
To evaluate prognostic value of complete disappearance of the tumor mass in contrast enhanced computerized tomography after initial treatment, 81 patients with supratentorial malignant astrocytomas (57 anaplastic astrocytomas and 24 glioblastomas) were divided into two groups. All complete response CR patients received the gross total resection (more than 95% resection). Average age of this group was significantly younger than that of noncomplete response patients (38.4 vs. 49.7 years old, p < 0.05; Student t-test). In the complete response group, median survival duration was 58 months, 2-year survival rate was 77%, and 5-year survival rate was 34% compared to 12 months, 29%, and 10%, respectively, in the noncomplete response group. The outcome of CR group was significantly better (p < 0.001; Wilcoxon test). Therefore, complete response at completion of the initial treatment is an important predictor of longer survival. Gross total resection is essential to obtain complete response and thus plays a crucial role in the initial treatment of malignant astrocytomas.
Similar articles
-
Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors.J Formos Med Assoc. 1993 Mar;92(3):220-6. J Formos Med Assoc. 1993. PMID: 8102273
-
Impact of neuronavigation and image-guided extensive resection for adult patients with supratentorial malignant astrocytomas: a single-institution retrospective study.Minim Invasive Neurosurg. 2004 Oct;47(5):278-83. doi: 10.1055/s-2004-830093. Minim Invasive Neurosurg. 2004. PMID: 15578340
-
Hemispheric supratentorial low-grade astrocytoma.Neurochirurgia (Stuttg). 1992 Jan;35(1):18-22. doi: 10.1055/s-2008-1052239. Neurochirurgia (Stuttg). 1992. PMID: 1570044
-
Management of supratentorial low-grade gliomas.Oncology (Williston Park). 1993 Jul;7(7):97-104, 107; discussion 108-11. doi: 10.1016/1053-4296(91)90006-s. Oncology (Williston Park). 1993. PMID: 8347464 Review.
-
[Prognostic factors in malignant gliomas].Gan To Kagaku Ryoho. 1996 Apr;23(5):643-8. Gan To Kagaku Ryoho. 1996. PMID: 8678527 Review. Japanese.
Cited by
-
Can diffusion tensor metrics help in preoperative grading of diffusely infiltrating astrocytomas? A retrospective study of 36 cases.Neuroradiology. 2011 Jan;53(1):63-8. doi: 10.1007/s00234-010-0761-y. Epub 2010 Sep 1. Neuroradiology. 2011. PMID: 20809287
-
Conditional survival of high-grade glioma in Los Angeles County during the year 1990-2000.J Neurooncol. 2012 Oct;110(1):145-52. doi: 10.1007/s11060-012-0949-6. Epub 2012 Aug 9. J Neurooncol. 2012. PMID: 22875707
-
Analysis of the extent of astrocytic tumour resection evaluated by magnetic resonance images.Neurosurg Rev. 2003 Oct;26(4):262-5. doi: 10.1007/s10143-003-0280-y. Epub 2003 Jun 19. Neurosurg Rev. 2003. PMID: 12820021
-
Evaluation of Diffusion Anisotropy and Diffusion Shape in Grading of Glial Tumors.J Biomed Phys Eng. 2019 Aug 1;9(4):459-464. doi: 10.31661/jbpe.v0i0.513. eCollection 2019 Aug. J Biomed Phys Eng. 2019. PMID: 31531299 Free PMC article.
-
Diffusion Tensor Imaging for Glioma Grading: Analysis of Fiber Density Index.Basic Clin Neurosci. 2017 Jan;8(1):13-18. doi: 10.15412/J.BCN.03080102. Basic Clin Neurosci. 2017. PMID: 28446945 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical